Integra LifeSciences Corporation Sustainability Profile
Integra LifeSciences Corporation, a leading global medical technology company, is headquartered in the United States. Founded in 1989, Integra has established itself in the fields of neurosurgery, orthopaedics, and reconstructive surgery, providing innovative solutions that enhance patient outcomes. With a diverse portfolio of products, including advanced wound care, surgical instruments, and regenerative medicine, Integra stands out for its commitment to quality and innovation. The company has achieved significant milestones, including the development of unique biomaterials that promote healing and tissue regeneration. Recognised for its strong market position, Integra LifeSciences continues to expand its reach across North America, Europe, and Asia, solidifying its reputation as a trusted partner in the healthcare industry.
DitchCarbon Score
How does Integra LifeSciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Integra LifeSciences Corporation's score of 44 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Integra LifeSciences Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is identified as a current subsidiary of Integra LifeSciences Holdings Corporation, which may influence its climate-related initiatives and reporting. While there are no documented reduction targets or climate pledges from Integra LifeSciences Corporation, it is important to note that emissions data and performance metrics may be inherited from its parent company, Integra LifeSciences Holdings Corporation. This cascading of data suggests that any climate commitments or emissions reductions would align with the broader strategies of the parent organisation. As of now, Integra LifeSciences Corporation has not publicly committed to specific science-based targets or initiatives such as those outlined by the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The lack of detailed emissions data and reduction initiatives highlights an opportunity for the company to enhance its climate commitments and transparency in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 13,902,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 18,609,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Integra LifeSciences Corporation's Industry?
How Carbon Intensive is Integra LifeSciences Corporation's Location?
Integra LifeSciences Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Integra LifeSciences Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
